Ascorbate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1631 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | — | 8 | 22 | 21 | 2 | 26 | 71 |
| Colorectal neoplasms | D015179 | — | — | 15 | 17 | 22 | 1 | 6 | 54 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 7 | 7 | 9 | 9 | 22 | 52 |
| Anemia | D000740 | HP_0001903 | D64.9 | 1 | — | 11 | 10 | 30 | 52 |
| Iron deficiencies | D000090463 | — | — | — | 1 | 9 | 9 | 33 | 51 |
| Syndrome | D013577 | — | — | 9 | 16 | 8 | 1 | 20 | 49 |
| Iron-deficiency anemia | D018798 | HP_0001891 | D50 | — | 1 | 9 | 9 | 26 | 44 |
| Sepsis | D018805 | HP_0100806 | A41.9 | 3 | 15 | 11 | 3 | 7 | 35 |
| Infections | D007239 | EFO_0000544 | — | 4 | 6 | 11 | 3 | 12 | 34 |
| Septic shock | D012772 | — | A48.3 | 3 | 12 | 13 | 3 | 6 | 32 |
Show 180 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 15 | 38 | 25 | — | 4 | 74 |
| Healthy volunteers/patients | — | — | — | 19 | 3 | 3 | — | 32 | 56 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | — | 8 | 26 | 22 | — | 2 | 52 |
| Lymphoid leukemia | D007945 | — | C91 | 8 | 25 | 20 | — | 2 | 49 |
| Neoplasms | D009369 | — | C80 | 23 | 19 | 4 | — | 2 | 41 |
| Lymphoma | D008223 | — | C85.9 | 6 | 20 | 11 | — | 2 | 36 |
| Prostatic neoplasms | D011471 | — | C61 | 4 | 20 | 9 | — | 4 | 35 |
| Adenocarcinoma | D000230 | — | — | 12 | 21 | 7 | — | — | 34 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 16 | 20 | 4 | — | — | 33 |
| Carcinoma | D002277 | — | C80.0 | 10 | 12 | 5 | — | — | 24 |
Show 154 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myelodysplastic syndromes | D009190 | — | D46 | 7 | 9 | — | — | 4 | 18 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 10 | 6 | — | — | 3 | 17 |
| Preleukemia | D011289 | — | — | 7 | 8 | — | — | 3 | 16 |
| Multiple myeloma | D009101 | — | C90.0 | 7 | 10 | — | — | 3 | 16 |
| Myeloid leukemia | D007951 | — | C92 | 9 | 7 | — | — | 1 | 15 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 7 | 4 | — | — | 5 | 14 |
| Plasma cell neoplasms | D054219 | — | — | 7 | 9 | — | — | 1 | 13 |
| Non-small-cell lung carcinoma | D002289 | — | — | 7 | 7 | — | — | — | 11 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 2 | 1 | — | — | 7 | 10 |
| Obstructive lung diseases | D008173 | HP_0006536 | — | 2 | 1 | — | — | 7 | 10 |
Show 181 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | — | — | — | 3 | 5 |
| Psoriasis | D011565 | EFO_0000676 | L40 | 4 | — | — | — | 1 | 5 |
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | 3 | 5 |
| Melanoma | D008545 | — | — | 4 | — | — | — | — | 4 |
| Macular edema | D008269 | — | — | 2 | — | — | — | 2 | 4 |
| Skin neoplasms | D012878 | EFO_0004198 | C44 | 2 | — | — | — | 2 | 4 |
| Heart disease risk factors | D000082742 | — | — | 2 | — | — | — | 2 | 4 |
| Edema | D004487 | HP_0000969 | R60.9 | 2 | — | — | — | 1 | 3 |
| Dermatitis | D003872 | HP_0011123 | L30.9 | 1 | — | — | — | 2 | 3 |
| Bacterial infections | D001424 | — | A49 | 1 | — | — | — | 2 | 3 |
Show 66 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 8 | 8 |
| Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 6 | 6 |
| Hypotrichosis | D007039 | HP_0008070 | — | — | — | — | — | 5 | 5 |
| Respiratory sounds | D012135 | HP_0010307 | R06.1 | — | — | — | — | 4 | 4 |
| Crohn disease | D003424 | EFO_0000384 | K50 | — | — | — | — | 4 | 4 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 4 | 4 |
| Hyperlipidemias | D006949 | HP_0003077 | E78.5 | — | — | — | — | 4 | 4 |
| Tendinopathy | D052256 | EFO_1001434 | M77.9 | — | — | — | — | 4 | 4 |
| Healthy diet | D000072001 | — | — | — | — | — | — | 4 | 4 |
| Diet therapy | D004035 | — | — | — | — | — | — | 3 | 3 |
Show 246 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
5,153 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use